Webinar: Scalable strategies for dual production of MSC and their derived EV
Watch the webinar |
|||
We would like to invite you to rewatch our webinar, “Scalable Strategies for Dual Production of MSC and Their Derived Extracellular Vesicles (EVs).” This session will focus on recent advancements in scalable MSC and EV production systems and is intended for professionals in cell therapy and regenerative medicine. Webinar TopicsDr. Teresa Mendes from the iBB Group will present a series of approaches developed by her team, addressing:
|
|||
About the Speaker
Watch the webinar
|
|||
About AventaCell BioMedical Corp.AventaCell BioMedical Corp. is a leader in human-derived products for cell culture and tissue regeneration, with a focus on serum-free solutions for translational research. The Helios Bioscience product line supports the efficient expansion of various cell types, including MSCs and immunocells, essential for regenerative medicine research. |
|||